Effect of treatment with bupropion on EEG sleep: Relationship to antidepressant response

International Journal of Neuropsychopharmacology

Volumn 7, Issue 3, 2004, Pages 275-281

  Ott, Geoffrey E ^a   Rao, Uma ^b   Lin, Keh Ming ^a   Gertsik, Lev ^c   Poland, Russell E ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Antidepressant; Bupropion; Depression; Sleep

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; IMIPRAMINE; NORTRIPTYLINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DRUG EFFECT; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MENTAL DISEASE; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REM SLEEP; SCORING SYSTEM; SLEEP WAKING CYCLE; SUSTAINED RELEASE PREPARATION; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; DELAYED-ACTION PREPARATIONS; DEPRESSIVE DISORDER, MAJOR; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SLEEP; SLEEP, REM;

EID: 4444367752     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145704004298     Document Type: Article

References (59)

1. APA (1994). Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Press.
2. Benca RM, Obermeyer WH, Thisted RA, Gillin JC (1992). Sleep and psychiatric disorders: a meta-analysis. Archives of General Psychiatry 49, 651-668.
3. Berger M, Riemann D (1993). REM sleep in depression - an overview. Journal of Sleep Research 2, 211-223.
4. Breslau N, Roth T, Rosenthal L, Andreski P (1996). Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biological Psychiatry 39, 411-418.
5. Cabeza RDJ, Zoltoski RK, Gillin JC (1994). Biochemical pharmacology of sleep. In: Chakroverty S (Ed.), Sleep Disorders Medicine (pp. 37-56). Boston, MA: Butterworth-Heinemann.
6. Cooper BR, Hester TJ, Maxwell RA (1980). Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine in vivo. Journal of Pharmacology and Experimental Therapeutics 215, 127-134.
7. Cooper BR, Wang CM, Cox RF, Norton R, Shea V, Ferris RM (1994). Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism. Neuropsychopharmacology 11, 133-141.
8. Dunleavy DLF, Oswald I (1973). Phenelzine: mood response and sleep. Archives of General Psychiatry 28, 353-356.
9. Ferris RM, White HL, Cooper BR, Maxwell RA, Tang FLM, Beaman OJ, Russell A (1981). Some neurochemical properties of a new antidepressant, bupropion hydrochloride (Wellbutrin). Drug Development Research 1, 21-35.
10. First MB, Spitzer RL, Gibbon M, Williams JB (1994). Structured Clinical Interview for DSM-IV Axis I Disorders: SCID-I Clinician Version. Washington, DC: American Psychiatric Association.
11. Ford DE, Kamerow DB (1989). Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? Journal of the American Medical Association 262, 1479-1484.
12. Giles DE, Jarrett RB, Roffwarg HP, Rush J (1987). Reduced rapid eye movement latency: a predictor of recurrence in depression. Neuropsychopharmacology 1, 33-39.
13. Giles DE, Kupfer DJ (1994). Reduced REM latency: risk factor for first episode of depression. Sleep Research 23, 197.
14. Gillin JC, Wyatt RJ, Fram D, Snyder F (1978). The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline. Psychopharmacology 59, 267-272.
15. Grunhaus L, Shipley JE, Eiser A, Pande AC, Tandon R, Remen A, Greden J (1994). Shortened REM latency post ECT is associated with rapid recurrence of depressive symptomatology. Biological Psychiatry 36, 214-222.
16. Hamilton M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 25, 56-62.
17. Hochli D, Riemann D, Zulley J, Berger M (1986). Initial REM sleep suppression by clomipramine: a prognostic tool for treatment response in patients with a major depressive disorder. Biological Psychiatry 21, 1217-1220.
18. Kupfer DJ (1976). REM latency: a psychobiologic marker for primary depressive disease. Biological Psychiatry 11, 159-174.
19. Kupfer DJ (1995). Sleep research in depressive illness: clinical implications - a tasting menu. Biological Psychiatry 38, 391-403.
20. Kupfer DJ, Coble P, Kane J, Petti T, Conners CK (1979). Imipramine and EEG sleep in children with depressive symptoms. Psychopharmacology 60, 117-123.
21. Kupfer DJ, Foster G, Reich L, Thompson KS, Weiss B (1976). EEG sleep changes as predictors in depression. American Journal of Psychiatry 133, 622-626.
22. Kupfer DJ, Frank E, McEachran AB, Grochocinski VJ (1990). Delta sleep ratio: a biological correlate of early recurrence in unipolar affective disorder. Archives of General Psychiatry 47, 1100-1105.
23. Kupfer DJ, Spiker DG, Coble PA, Neil JF, Ulrich R, Shaw DH (1981). Sleep and treatment prediction in endogenous depression. American Journal of Psychiatry 138, 429-434.
24. Kupfer DJ, Spiker DG, Rossi A, Coble PA, Shaw D, Ulrich R (1982). Nortriptyline and EEG sleep in depressed patients. Biological Psychiatry 17, 535-546.
25. Landolt H-P, Raimo EB, Schnierow BJ, Kelsoe JR, Rapaport MH, Gillin JC (2001). Sleep and sleep electroencephalogram in depressed patients treated with phenelzine. Archives of General Psychiatry 58, 268-276.
26. Little JT, Ketter TA, Mathe AA, Frye MA, Luckenbaugh D, Post RM (1999). Venlafaxine but not bupropion decreases cerebrospinal fluid 5- hydroxyindoleacetic acid in unipolar depression. Biological Psychiatry 45, 285-289.
27. McCarley RW, Greene RW, Rainnie D, Portas CM (1995). Brainstern neuromodulation and REM sleep. Seminars in Neuroscience 7, 341-354.
28. Mendlewicz J, Kempenaers C, de Maertelaer V (1991). Sleep EEG and amitriptyline treatment in depressed inpatients. Biological Psychiatry 30, 691-702.
29. 18F)-FDG PET. Psychiatry Research: Neuroimaging Section 106, 95-111.
30. 18F)FDG PET studies. Psychiatry Research: Neuroimaging Section 91, 59-78.
31. Nofzinger EA, Reynolds III CF, Thase ME, Frank E, Jennings JR, Fasiczka AL, Sullivan LR, Kupfer DJ (1995). REM sleep enhancement by bupropion in depressed men. American Journal of Psychiatry 152, 274-276.
32. Ott GE, Rao U, Nuccio I, Lin K-M, Poland RE (2002). Effect of bupropion-sr on REM sleep: relationship to antidepressant response. Psychopharmacology 165, 29-36.
33. Poland RE, McCracken JT, Lutchmansingh P, Lesser IM, Tondo L, Edwards C, Boone KB, Lin K-M (1997). Differential response of rapid eye movement sleep to cholinergic blockade by scopolamine in currently depressed, remitted, and normal control subjects. Biological Psychiatry 41, 929-938.
34. Poland RE, Tondo L, Rubin RT, Trelease RB, Lesser IM (1989). Differential effects of scopolamine on nocturnal cortisol secretion, sleep architecture, and REM latency in normal volunteers: relation to sleep and cortisol abnormalities in depression. Biological Psychiatry 25, 403-412.
35. Preskorn SH, Othmer SC (1984). Evaluation of bupropion hydrochloride: the first of a new class of atypical antidepressants. Pharmacotherapy 4, 20-34.
36. Rao U, Dahl RE, Ryan ND, Birmaher B, Williamson DE, Giles DE, Rao R, Kaufman J, Nelson B (1996). The relationship between longitudinal clinical course, sleep and cortisol changes in adolescent depression. Biological Psychiatry 40, 474-484.
37. Rechtschaffen A, Kales AA (1968). A Manual of Standardized Terminology, Techniques, and Scoring System for Sleep of Human Subjects. Los Angeles, CA: UCLA Brain Information Service.
38. Reynolds III CF (1998). What do antidepressant effects on sleep tell us about pathways to treatment response? Biological Psychiatry 44, 1-2.
39. Reynolds III CF, Hoch CC, Buysse DJ, George CJ (1991). Sleep in late-life recurrent depression: changes during early continuation therapy with nortriptyline. Neuropsychopharmacology 5, 85-96.
40. Reynolds CF, Perel JM, Frank E, Imber S, Kupfer DJ (1989). Open trial maintenance nortriptyline in geriatric depression: survival analysis and preliminary data on the use of REM latency as a predictor of recurrence. Psychopharmacology Bulletin 25, 129-132.
41. Rush AJ, Armitage R, Gillin JC, Yonkers KA, Winokur A, Moldofsky H, Vogel GW, Kaplita SB, Fleming JB, Montplaisir J, Erman MK, Albala BJ, McQuade RD (1998). Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorders. Biological Psychiatry 44, 3-14.
42. Rye DB, Dihenia B, Bliwise DL (1998). Reversal of atypical depression, sleepiness, and REM-sleep propensity in narcolepsy with bupropion. Depression and Anxiety 7, 92-95.
43. Schittecatte M, Dumont F, Machowski R, Cornil C, Lavergne F, Wilmotte J (2002). Effects of mirtazapine on sleep polygraphic variables in major depression. Neuropsychobiology 46, 197-201.
44. Sharpley AL, Cowen PJ (1995). Effect of pharmacologic treatments on the sleep of depressed patients. Biological Psychiatry 37, 85-98.
45. Sharpley AL, Walsh AES, Cowen PJ (1992). Nefazodone - a novel antidepressant - may increase REM sleep. Biological Psychiatry 31, 1070-1073.
46. Sharpley AL, Williamson DJ, Attenburrow MEJ, Pearson G, Sargent P, Cowen PJ (1996). The effects of paroxetine and nefazodone on sleep: a placebo controlled trial. Psychopharmacology 126, 50-54.
47. Siegel JM (1994). Brainstem mechanisms generating REM sleep. In: Kryger MH, Roth T, Dement WC (Eds.), Principals and Practice of Sleep Medicine (pp. 125-144). Philadelphia, PA: W. B. Saunders Company.
48. Staedt J, Hunerjager H, Ruther E, Stoppe G (1998). Sleep cluster arousal analysis and treatment response to heterocyclic antidepressants in patients with major depression. Journal of Affective Disorders 49, 221-227.
49. Staner L, Kerkhofs M, Detroux D, Leyman S, Linkowski P, Mendlewicz J (1995). Acute, subchronic, and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression. Sleep 18, 470-477.
50. Thase ME (1998). Depression, sleep, and antidepressants. Journal of Clinical Psychiatry 59 (Suppl. 4), 55-65.
51. Thase ME, Fasiczka AL, Berman SR, Simons AD, Reynolds III CF (1998). Electroencephalographic sleep profiles before and after cognitive behavior therapy of depression. Archives of General Psychiatry 55, 138-144.
52. van Bemmel AL, Havermans AG, van Diest R (1992). Effects of trazodone on EEG sleep and clinical state in major depression. Psychopharmacology 107, 569-574.
53. van Bemmel AL, van den Hoofdakker RH, Beersma DGM, Bouhuys AL (1993). Changes in sleep polygraphic variables and clinical state in depressed patients during treatment with citalopram. Psychopharmacology 113, 225-230.
54. Vogel GW, Buffenstein A, Minter K, Hennessey A (1990). Drug effects on REM sleep and on endogenous depression. Neuroscience and Behavior Review 14, 49-63.
55. Ware JC, Rose FV, McBrayer RH (1994). The acute effects of nefazodone, trazodone and buspirone on sleep and sleep-related penile tumescence in normal subjects. Sleep 17, 544-550.
56. Wilson SJ, Bell C, Coupland NJ, Nutt DJ (2000). Sleep changes during long-term treatment of depression with fluoxamine - a home based study. Psychopharmacology 149, 360-365.
57. Winokur A, Gary KA, Rodner S, Rae-Red C, Fernando AT, Szuba MP (2001). Depression, sleep physiology, and antidepressant drugs. Depression and Anxiety 14, 19-28.
58. Wu JC, Buchsbaum M, Bunney WE (2001). Clinical neurochemical implications of sleep deprivation's effects on the anterior cingulate of depressed responders. Neuropsychopharmacology 25, S74-S78.
59. Wyatt RJ, Kupfer DJ, Scott J, Robinson DS, Snyder F (1969). Longitudinal studies of the effect of monoamine oxidase inhibitors on sleep in man. Psychopharmacologia 15, 236-244.